Ventus Therapeutics Saved $150K+ and Scaled Research Without Adding Headcount
As Ventus expanded operations across the U.S. and Canada, rapid growth introduced new complexity.
Administrative strain: Scientists lost valuable time to manual tasks without dedicated lab operations support.
Rising workload: A lean AP team faced growing pressure as order volume increased.
Limited visibility: Financial reporting and compliance became more difficult without centralized systems.
To scale efficiently, Ventus implemented the Prendio-BioProcure platform and services to maintain research velocity.
3-way match functionality: A key factor in their decision, ensuring accuracy and control across purchasing and payments.
Seamless onboarding: More than 50 users adopted the platform smoothly, with workflows aligned to existing processes.
Integrated approach: Combined technology and services to support growth without adding operational burden.
Ventus achieved measurable results through a life science procurement transformation that reduced costs and boosted productivity.
$150K+ cost savings reinvested in advancing their science.
Hundreds of hours saved by automating and streamlining procurement workflows.
Stronger vendor relationships and accuracy through automated invoice processing and financial tracking.
Prendio-BioProcure expanded our team without having to make a full-time hire. It is very flexible, and as we continue to grow and continue to hire, we’re able to use the same system. We have worked with the team to find various cost saving initiatives like sourcing from other vendors than the ones we typically use, setting up annual POs for repeat lab supplies, etc.
Yelena Shuster-Rosen Controller, Ventus Therapeutics
Ventus Therapeutics is a Series C clinical-stage biotech with locations in the United States and Canada, developing novel small-molecule therapies for hard-to-target proteins in immunology, inflammation, andneurology.